Ryvu Therapeutics

BIO-Europe is in full swing, and we're right in the middle of it! Join Magda Marciniak and Andrew Thomason for exciting discussions and new opportunities. Whether you're looking to explore new partnerships or dive into the latest in drug discovery, don't miss the chance to meet with them. Reach out through the partnering system, and let’s start a conversation! #RyvuTx #BIOEU #LifeSciences #Partnerships

Last week, we celebrated a new milestone at Ryvu and launched a tradition that will continue to honor our mission of improving the lives of cancer patients. Moving forward, each time we identify a preclinical candidate, we’ll create a mural dedicated to the project, capturing the dedication, challenges, and accomplishments that got us there. Alongside each mural, we'll bury a time capsule crafted by the project team—a lasting tribute to their hard work and innovations. Our first mural commemorates the PRMT5 project. To kick things off, we held a mural design contest among Ryvers, with the final painting based on artwork created by one of our employees! 🌟 Below a short relation from this event. Good job everyone!  Let’s hope we will soon see another mural!

Join us on November 6-7 at the World ADC Conference in San Diego! Vatnak Vat-Ho, Chief Business Officer, and Mateusz Nowak, Director of Early Discovery and Innovation, will be presenting Ryvu and are excited to discuss our latest advancements. Don’t miss this chance to connect and collaborate! See you there! #RyvuTx #WorldADC #BiotechInnovation #ADC

Zapraszamy na VI Forum Forum PHARMA PLANET 360∘, które odbędzie się już 6-7 listopada 2024 r. w Warszawie! W tym roku wraz z Justyna Żółtek, naszą Chief People Officer, będziemy analizować, w jaki sposób sztuczna inteligencja i dane HR mogą wpłynąć na funkcjonowanie działu HR i całej organizacji. Dołącz do Justyny już 📅 7 listopada o godz. 15:50 i dowiedz się: 💡Czy wykorzystanie narzędzi AI w firmie specjalizującej się w odkrywaniu innowacyjnych terapii onkologicznych niesie ze sobą jakieś zagrożenia? 💡 Czy sztuczna inteligencja i analiza danych mogą ułatwić zarządzanie zasobami ludzkimi? 💡 Z jakimi obawami wiąże się wykorzystanie AI w pracy działów HR? Z kim widzimy się w Warszawie? #RyvuTx #AI #ArtificialIntelligence #HR #PharmaPlanet ************************************* Join us at the VI PHARMA PLANET 360° Forum in Warsaw on November 6-7, 2024! This year, our Chief People Officer, Justyna Żółtek, will explore the impact of artificial intelligence and HR data on HR departments and the broader organization. Don’t miss Justyna’s session on 📅 November 7 at 3:50 p.m., where she'll address key questions such as: 💡 What risks do AI tools pose for companies focused on innovative oncology therapies? 💡 How can artificial intelligence and data analysis streamline HR management? 💡 What ethical concerns arise from using AI in HR departments? Who’s joining us in Warsaw?

We’re attending BIO-Europe! Join us! Our Director of Business Development & Alliance Management, Magda Marciniak, and Drug Discovery Director, Andrew Thomason, are eager to connect! 🤝 Feel free to reach out to us via the partnering system! Find out more: https://lnkd.in/dnuNZ2D Looking forward to seeing you there! #RyvuTx #BIOEU #LifeSciences #Partnerships

Ryvu Therapeutics is thrilled to announce a research collaboration with nCage Therapeutics to develop a next-generation antibody-drug conjugate (ADC) platform. Our Chief Scientific Officer, Krzysztof Brzozka, underlines: "This collaboration is an exciting opportunity to combine our small molecule expertise and experience with novel ADC payloads with the strong team at nCage, who are working on a truly novel delivery platform. We are encouraged by the growing field of next-generation ADCs and the potential for this collaboration to generate more effective and safer therapies." Ryvu and nCage foresee a long-term partnership to significantly enhance the TRAP cage for drug delivery, potentially leading to breakthrough oncology therapies.  Read more: https://lnkd.in/di7Xz5pg #RyvuTherapeutics #nCageTherapeutics #ADC #CancerResearch #NextGenTherapies #BiotechInnovation

Rafal Wojdan, our Director of Data Science, will be speaking at the Chief Data and Analytics Officers (CDAO) conference in Frankfurt this October! Rafał will lead a discussion group on “Why is data democratisation so challenging, and what can we do about it?" exploring data transformation from the perspectives of data talent and data democratisation. 📅 Join us in Frankfurt on October 30th for an inspiring in-person event. Don’t miss this opportunity to gain insights from Rafał and other industry leaders! We start at 2:00 PM CET! Register now: https://lnkd.in/dSYchiuZ

We're thrilled to announce the kickoff of the 3rd edition of our Leadership Development Program: Take a Lead! 🎯 This comprehensive training initiative is designed to empower leaders across the company with skills, and knowledge to drive growth and support creativity.   This program will focus on development in areas like leadership, business, and people management.   This program is connected with the one of Ryvu value GO BEYOND, focuses on developing leaders who are willing to push boundaries, exceed expectations, and foster innovation.   Let’s grow together! 💼   #Leadership #Training #Growth #GoBeyond

Join us for a webinar! Learn more about our progress in RVU120, RVU305, WRN programs, and the ONCO Prime Platform. We’ll be streaming live from the 2024 EORTC-NCI-AACR Symposium in Barcelona!   📅 October 25, 11:00 AM CET Don’t miss out—register today and be part of the conversation! ➡ https://lnkd.in/d2u8VDR5   #RyvuTx #OncologyResearch #ENASymposium #CancerTreatment #SyntheticLethality #DrugDiscovery #RVU120 #RVU305 #WRN #EORTC  #NCI #AACR #ENA #ADC #smallmolecules

We're super excited to be at #ENA2024! We appreciate the interest in our scientific achievements, and we are fully prepared to engage in discussions, explain, and delve deeper into our clinical and preclinical data on RVU120, RVU305, and novel synthetic lethality programs. Whether you're curious about our research, seeking collaboration, or simply looking to connect, we’re here to answer your questions and explore new opportunities together. Catch you here at ENA2024! 🙌 #RyvuTx #Ryvers #OncologyResearch #ENASymposium #CancerTreatment #SyntheticLethality #DrugDiscovery #RVU120 #RVU305 #WRN #EORTC #NCI #AACR #ENA #ADC #smallmolecules